FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Warns 2 Firms Over Illegal Weight-Loss Drugs

FDA warns Miami, FL-based US Chem Labs and Bronx, NY-based Helix Chemical that they are selling unapproved and misbranded versions of the popular bran...

latest-news-card-1
Human Drugs

ICH Draft Guide on Post-Approval Safety Data

FDA publishes an ICH draft guideline on post-approval safety data that is available for comment.

Medical Devices

Nanox Fatty Liver Detector Cleared by FDA

FDA clears a Nanox AI 510(k) for HealthFLD, an artificial intelligence software that provides automated qualitative and quantitative analysis of liver...

latest-news-card-1
Medical Devices

FDA Getting Stricter on Cybersecurity Enforcement

Former FDAer Naomi Schwartz says medical device companies must prioritize cybersecurity compliance to meet a stricter FDA enforcement emphasis.

latest-news-card-1
Medical Devices

FDA Clears Masimo OTC Pulse Oximeter

FDA clears a Masimo 510(k) for its MightySat Medical, an over-the-counter fingertip pulse oximeter.

latest-news-card-1
Human Drugs

FDA Issues Data Monitoring Committee Draft Guide

FDA makes available a draft guidance entitled Use of Data Monitoring Committees in Clinical Trials.

latest-news-card-1
Federal Register

Rule on Biologic Use of Master Files

Federal Register notice: FDA issues a final rule to amend its regulations to address the use of master files by applications licensed under the Public...

latest-news-card-1
Human Drugs

Priority Review for Lykos NDA for PTSD

FDA accepts for priority review a Lykos Therapeutics NDA for midomafetamine capsules used in combination with psychological intervention for treating ...

latest-news-card-1
Human Drugs

Draft Guide on Advanced Manufacturing Technologies

FDA makes available a draft guidance entitled FDA Advanced Manufacturing Technologies Designation Program.

latest-news-card-1
Federal Register

Workshop on Generic Drug Science

Federal Register notice: FDA announces a 5/20-21 public workshop entitled FY 2024 Generic Drug Science and Research Initiatives Workshop.